Cedric Bruel

Cedric Bruel

Auto-generated profile, based on publicly available information

Cedric Bruel

IctalGroup, Le Chesnay, France; Service de Réanimation Polyvalente, Groupe Hospitalier Paris Saint Joseph, Paris, France

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Annals of Intensive Care
Verified
Journal Article
Open access
PDF file
MGMaité Garrouste-Orgeas
Maité Garrouste-Orgeas
Francois PhilippartFrancois Philippart
Francois Philippart
CBCédric Bruel
Cédric Bruel
AMAdeline Max
Adeline Max
NLNicolas Lau
Nicolas Lau
BMBenoît Misset
Benoît Misset
Safety is a global concept that encompasses efficiency, security of care, reactivity of caregivers, and satisfaction of patients and relatives. Patient safety has emerged as a major target for healthcare improvement. Quality assurance is a complex task, and patients in the intensive care unit (ICU) are more likely than other hospitalized patients to experience medical errors, due to the complexity of their conditions, need for urgent interventions, and considerable workload fluctuation. Medication errors are the most common medical errors and can induce adverse events. Two approaches are available for evaluating and improving quality-of-care: the room-for-improvement model, in which problems are identified, plans are made to resolve them, and the results of the plans are measured; and the monitoring model, in which quality indicators are defined as relevant to potential problems and then monitored periodically. Indicators that reflect structures, processes, or outcomes have been developed by medical societies. Surveillance of these indicators is organized at the hospital or national level. Using a combination of methods improves the results. Errors are caused by combinations of human factors and system factors, and information must be obtained on how people make errors in the ICU environment. Preventive strategies are more likely to be effective if they rely on a system-based approach, in which organizational flaws are remedied, rather than a human-based approach of encouraging people not to make errors. The development of a safety culture in the ICU is crucial to effective prevention and should occur before the evaluation of safety programs, which are more likely to be effective when they involve bundles of measures.

3 June 2020 in Neurocritical Care
Verified
Journal Article
Closed access
PDF file
SLStephane Legriel
Stephane Legriel
GJGwenaëlle Jacq
Gwenaëlle Jacq
ALAmandine Lalloz
Amandine Lalloz
GGGuillaume Geri
Guillaume Geri
PMPedro Mahaux
Pedro Mahaux
ACAlain Cariou
Alain Cariou

18 March 2019 in BMC Medical Ethics
Verified
Journal Article
Open access
PDF file
SHSidonie Hubert
Sidonie Hubert
SWSarah Wainschtein
Sarah Wainschtein
AHAlbane Hugues
Albane Hugues
CSCaroline Schimpf
Caroline Schimpf
TDThècle Degroote
Thècle Degroote
Francois PhilippartFrancois Philippart
Francois Philippart
The doctor-patient relationship has evolved to respect “the autonomy and patients’ rights”. One of the cornerstones in such autonomy is the opportunity for patients to draw living wills, also known as advance directives (AD). However, information about AD available to patients remains scarce largely due to the lack of involvement of General practitioners for several reasons. The aim of our study was to evaluate current general practitioner residents’ (GPR) behavior concerning their role in informing their patients about AD. We built a French nationwide survey from GPR class of 2012 to 2014. Two thousand three hundred ten residents completed our survey (21.1% of the total population of GPR during the period). 89.8% declared their willingness to offer patients the opportunity of writing AD. When asked about the usefulness of AD, 73.6% of residents responded that these are a suitable help for patients, but 19.7% considered that AD are essentially geared towards frail patients. Among residents who want to inform patients about AD (n = 2075), 14.7% wanted to involve all patients. Only 20.5% thought that elderly people should be systematically informed about AD. When the question involves other frail people in various disease areas, information seems relevant for 60.1% of GPR considering patient with cancer or malignant hematologic disease and for 56.2% about patients affected by neurodegenerative disease. When considering the routine use of AD, 20.5% of GPR would take them into account only if they are in agreement with the patient’s decision. The results of the survey indicate that GPR would rather choose to decide who should be informed about AD, and when to take AD into account for ethical concerns.

28 October 2025 in Epilepsy & Behavior
Verified
Journal Article
Closed access
GJGwenaelle Jacq
Gwenaelle Jacq
GSGhada Sboui
Ghada Sboui
JLJean Baptiste Lascarrou
Jean Baptiste Lascarrou
PBPierre Bailly
Pierre Bailly
PBPascal Beuret
Pascal Beuret
SLStephane Legriel
Stephane Legriel

6 December 2019 in Médecine Intensive Réanimation
Verified
Journal Article
Closed access
PDF file
TDT. Degroote
T. Degroote
VCV. Chhor
V. Chhor
MTM. Tran
M. Tran
FPF. Philippart
F. Philippart
CBC. Bruel
C. Bruel
La cholécystite aiguë de réanimation (0,2 à 1 % des patients) est liée à des facteurs de risque spécifiques (jeûne, nutrition parentérale, ventilation mécanique) et systémiques (instabilité, brûlures graves, catécholamines) conduisant à des phénomènes d’ischémie-reperfusion de la paroi vésiculaire, à l’origine d’une cholécystite classiquement alithiasique. Toutefois, les données récentes retrouvent une participation lithiasique dans 50%des cas environ. Il s’agit d’une maladie grave dont le diagnostic est difficile et la mortalité élevée (40 %). Chez ces patients graves, aucun critère clinicobiologique ne permet un diagnostic de certitude. L’imagerie du patient de réanimation peut être prise à défaut par les anomalies fréquemment retrouvées en réanimation ; les signes les plus évocateurs sont un épaississement pariétal vésiculaire supérieur à 4 mm, un hydrocholécyste ou un défaut de rehaussement de la paroi au scanner. Le traitement en urgence repose sur une antibiothérapie à large spectre ciblée sur les germes digestifs et nosocomiaux ainsi que sur une optimisation hémodynamique. La cholécystectomie (laparoscopique, voire sous-costale) représente le traitement de référence en empêchant la récidive. Mais la gravité des patients amène souvent à envisager une solution moins lourde que la chirurgie avec un drainage de la vésicule. Le drainage par voie percutanée est l’alternative de choix en raison de sa disponibilité et de son efficacité, il existe toutefois un risque théorique de récidive à l’ablation du drain, surtout en cas de cholécystite lithiasique. Le drainage interne par voie endoscopique (transpapillaire ou transdigestif) est une possibilité prometteuse, mais réservée à l’heure actuelle aux centres experts.